Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2Phase NA 1Phase 4 1

Status

Unknown 11Completed 8Active not recruiting 7Withdrawn 4Recruiting 4Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Lymphoid 8

Conditions

Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 2Lymphoma, Non-Hodgkin 1Lymphoma 1HIV Infections 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Completed × R-CHOP protocol × Clear all
NCT01865110 2025-03-05

R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

The Lymphoma Academic Research Organisation

Phase 3 Completed
623 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT02633137 2024-08-30

Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
49 enrolled 8 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT00268853 2024-05-30

RAPID

CTI BioPharma

Phase 2 Completed
124 enrolled 13 charts
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02660710 2022-10-28

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
39 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

Kosin University Gospel Hospital

Phase 2 Completed
53 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00530179 2019-01-22

PET-Chop

AHS Cancer Control Alberta

Phase NA Completed
69 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00554164 2017-05-05

PETAL

University Hospital, Essen

Phase 3 Completed
1,073 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00466258 2009-11-25

LINFOTARGAM

PETHEMA Foundation

Phase 4 Completed
50 enrolled
Lymphoid

HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡